HAYS ADVISORY LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
HAYS ADVISORY LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2018$1,000
-100.0%
255
-100.0%
0.00%
-100.0%
Q4 2015$3,141,000
-39.5%
887,214
-14.0%
0.53%
-32.1%
Q3 2015$5,189,000
-22.2%
1,031,540
-0.6%
0.78%
-18.8%
Q2 2015$6,672,000
-15.3%
1,037,600
-7.3%
0.97%
-5.0%
Q1 2015$7,878,000
-7.8%
1,119,794
+1.1%
1.02%
-11.0%
Q4 2014$8,540,000
-11.9%
1,107,698
-14.7%
1.14%
-10.8%
Q3 2014$9,699,0001,298,4591.28%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,632,000$8,817,0002.83%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 551,804$1,848,543,0001.54%
Nine Chapters Capital Management LLC 24,300$81,0000.57%
GREAT POINT PARTNERS LLC 645,000$2,161,0000.55%
Virtus ETF Advisers LLC 198,901$666,0000.32%
GSA CAPITAL PARTNERS LLP 1,521,224$5,096,0000.27%
Amici Capital, LLC 200,000$670,0000.18%
Acrospire Investment Management LLC 70,622$237,0000.16%
RBF Capital, LLC 273,976$918,0000.16%
SECOR Capital Advisors, LP 383,971$1,286,0000.14%
View complete list of PDL BIOPHARMA INC shareholders